| cpd00902 | 1232235-89-0 | dipeptide | XHWX | Neomycin B derivative | Antimicrobial therapy, antibacterial (P. aeruginosa) | triazole | Bera, Smritilekha;et.al (2010)
DOI |
cpd00903 | 1232235-88-9 | dipeptide | XHGX | Neomycin B derivative | Antimicrobial therapy, antibacterial (P. aeruginosa) | triazole | Bera, Smritilekha;et.al (2010)
DOI | cpd00904 | 1207193-14-3 | [Tyr3]Octreotide | FCYWKTC | DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative | Anticancer therapy, AR42J cells | amide | Yim, Cheng-et.al (2010)
DOI | cpd00905 | 1207193-13-2 | [Tyr3]Octreotide | FCYWKTC | 3-(2-propyn-1-yloxy)-, S-[(2,4,6-trimethoxyphenyl)methyl] benzenecarbothioic acid ester | Anticancer therapy, AR42J cells | amide | Yim, Cheng-et.al (2010)
DOI | cpd00906 | 1227069-47-7 | [Tyr3]Octreotide, dimer | FCYWKTC | DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative | Anticancer therapy, AR42J cells | amide | Yim, Cheng-et.al (2010)
DOI | cpd00907 | 1227069-46-6 | [Tyr3]Octreotide, dimer | FCYWKTC | 3,5-bis(2-propyn-1-yloxy)-, S-[(2,4,6-trimethoxyphenyl)methyl] benzenecarbothioic acid ester | Anticancer therapy, AR42J cells | amide | Yim, Cheng-et.al (2010)
DOI | cpd00908 | 1220340-48-6 | oligopeptide | PQPSKSA | ADP ribose | Synthesis | amide | van der Heden van Noort, Gerbrand J.et.al (2010)
DOI | cpd00909 | 1220340-47-5 | oligopeptide | PQPSKSA | 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-β-D-ribofuranosyl azide | Synthesis | amide | van der Heden van Noort, Gerbrand J.et.al (2010)
DOI | cpd00910 | 1220340-46-4 | oligopeptide | VANIEV | ADP ribose | Synthesis | amide | van der Heden van Noort, Gerbrand J.et.al (2010)
DOI | cpd00911 | 1220340-45-3 | oligopeptide | VANIEV | 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-β-D-ribofuranosyl azide | Synthesis | amide | van der Heden van Noort, Gerbrand J.et.al (2010)
DOI | cpd00912 | 1220340-34-0 | oligopeptide | XNYX | 5-O-[(1,1-Dimethylethyl)diphenylsilyl]-β-D-ribofuranosyl azide | Synthesis | amide | van der Heden van Noort, Gerbrand J.et.al (2010)
DOI | cpd00913 | 1034334-81-0 | oligopeptide | EVNXVAEFXXXXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00914 | 1268472-49-6 | oligopeptide | EVNXXXXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00915 | 1268472-48-5 | oligopeptide | EVNXXXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00916 | 1268472-47-4 | oligopeptide | EVNXVAEFXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00917 | 1268472-46-3 | oligopeptide | EVNXXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00918 | 867062-93-9 | oligopeptide | EXGEVNXVAEFXXXXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00919 | 1268472-50-9 | oligopeptide | EVNXXXXXXXXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00920 | 1268472-45-2 | oligopeptide | EVNXVAEFXD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00921 | 1268472-44-1 | oligopeptide | EVNXVAEFD | Cholestanol | Alzheimer’s disease therapy, beta-secretase inhibition | amide | Schieb, Heinke;et.al (2010)
DOI | cpd00922 | 1293910-29-8 | octapeptide recognized and cleaved by MMP2 | GPLGIAGQ | pacitaxel derivative | Antitumor therapy, MDA-MB-435 and HT1080 cells | ester | Yamada, Roppei;et.al (2010)
DOI | cpd00923 | 1293910-28-7 | octapeptide recognized and cleaved by MMP3 | GPLGIAGQ | pacitaxel derivative | Antitumor therapy | ester | Yamada, Roppei;et.al (2010)
DOI | cpd00924 | 1293910-27-6 | octapeptide recognized and cleaved by MMP4 | GPLGIAGQ | pacitaxel derivative | Antitumor therapy | ester | Yamada, Roppei;et.al (2010)
DOI | cpd00925 | 1258942-82-3 | KK (plasma membrane delivery) | XKKX | alkyne-functionalized cysteine protease inhibitor L1 | Synthesis and inhibition of lysosomal cysteine proteases | triazole | Loh, Yuhui;et.al (2010)
DOI | cpd00926 | 1258942-81-2 | SV40 (nucleus delivery) | XKKKRKV | alkyne-functionalized cysteine protease inhibitor L1 | Synthesis and inhibition of lysosomal cysteine proteases | amide | Loh, Yuhui;et.al (2010)
DOI | cpd00927 | 1258942-80-1 | Tat (lysosome delivery) | XRKKRRQRRR | alkyne-functionalized cysteine protease inhibitor L1 | Synthesis and inhibition of lysosomal cysteine proteases | amide | Loh, Yuhui;et.al (2010)
DOI | cpd00928 | 1246180-10-8 | Neuropeptide Y derivative | YPSXXRHYINLTRQRY | 1-Fluoro-2-cyclooctyne-1-carboxylic acid + DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative) | Synthesis of radiolabeled conjugates | triazole | Martin, Molly E.et.al (2010)
DOI | cpd00929 | 1246180-10-8 | Neuropeptide Y derivative | YPSXXRHYINLTRQRY | 1-Fluoro-2-cyclooctyne-1-carboxylic acid + DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) derivative) | Synthesis of radiolabeled conjugates | triazole | Martin, Molly E.et.al (2010)
DOI | cpd00930 | 1252800-23-9 | dipeptide | XII | porphine derivative | Synthesis | triazole | Umezawa, Naoki;et.al (2010)
DOI | cpd00931 | 1067653-24-0 | nuclear localization sequences (NLS) | GPKKKRKV | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Anticancer therapy, photosensitizer | sulfonamide | Sibrian-et.al (2010)
DOI | 
